Escalon Medical
This article was originally published in The Gray Sheet
Executive Summary
Ophthalmic surgical and pharmaceutical product developer acquires Lake Success, New York-based ophthalmic ultrasound maker Sonamed for approximately $12.5 mil. in cash. Sonamed is profitable and recorded 1999 sales of about $7 mil. Separately, Escalon has decided to discontinue Phase I clinical trials of its Ocufit SR ophthalmic drug delivery system it has been developing jointly with West Pharmaceutical Services. Escalon cites poor initial results in a Jan. 18 release
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.